Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1994-05-11
1995-08-01
Russel, Jeffrey E.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
4242531, 530806, 530825, A61K 3910, C07K 14235
Patent
active
054381207
ABSTRACT:
Purified Bordetella pertussis antigen having a molecular weight between 67,000 and 69,000 and determined by 12% (W/W) polyacrylamide gel electrophoresis and a proline glutamic acid ratio of substantially 1:1 as determined by amino acid analysis.
REFERENCES:
patent: 3141824 (1964-07-01), Dahlstrom
patent: 3395219 (1968-07-01), Millman
patent: 3465078 (1969-09-01), Spiesel
patent: 4248862 (1981-02-01), Ellwood et al.
patent: 4551429 (1985-11-01), Greenspan
patent: 5237052 (1993-08-01), Novotny
Proc. Natl. Acad. Sci. USA, vol. 86, Issued 1989, Charles et al, "Molecular Cloning and Characteriztion of Protective Outer . . . ", pp. 3554-3558.
Turco et al (1983) Infection and Immunity 42 27-32.
Stainer et al (1971) J. of General Microbiology 63 211-220.
Novotny et al (1975) J. of Biological Standardisation 3 11-29.
English language abstract of reference 4 (abstract No. 408 (abstract No. 40872S).
Brennan (1988) Infection and Immunity 56 3189-3195.
Pittman (1984) Pediatric Infections Disease 3 467-486.
Novotny et al (1985) Infection and Immunity 50 190-198.
Novotny et al (1987) Rec. Med. Vet. 163 431-438.
Moss et al (1984) Annals of Internal Medicine 101 653-666.
Redhead et al (1984) Infection and Immunity 44 724-729.
Hewlett et al (1978) Advances in Cyclic Nucleotide Research 9 621-628.
Novotny et al (1985) Infection and Immunity 50 199-206.
Montaraz et al (1985) Infection and Immunity 47 744-751.
Domenighini et al (1990) Molecular Microbiology 4 (5) 787-800.
Abstract No. 84-033077/06 Abstract of JP-A-58-222 032.
Abstract No. 84-285037/46 Abstract of JP-A-59-175 439.
Abstract No. 84-284448/46 Abstract of JP-A-59-063 183.
Pittman (1979) Reviews of Infectious Diseases 1 401-412.
Gonzalez (1982) JAMA 248 22-23.
Novotny et al (1991) The Journal of Infectious Diseases 164 114-122.
Kobisch et al (1990) Infection and Immunity 58 352-357.
Hewlett et al. "Soluble Adenylate Cyclase from the Culture Medium of Bordatella pertussis," J. Bacteriology, Aug. 1976, pp. 890-898.
Chemical Abstract 87:130,172 (1977), Hewletlt et al, "Adenyl Cyclase in Bordatella pertussis vaccines", J. Infect. Dis. 1977, 136 (Suppl.); 216-19.
Manclark et al, Bacterial Vaccine, Germonier, ed. Chapter 3, pp. 72-75.
E. Hewlett et al., J.B.O. Chem., May 8, 1989, 6 pages, Adenylate Cyclase Toxin form Bordatella pertussis.
Paper-Pertussis, p. 69, Nov. 9, 1989.
Staden, Nucleic Acids Research, No. 9, 1982, pp. 2951-2961.
I. G. Charles, et al., Proc. Natl. Acad. Sci. USA, vol. 86, May 1989, pp. 3554-3558, Molecular cloning and characterization of protective outer membrane protein p. 69 from Bordatella pertussis.
P. Glaser, et al., Molecular Microbiology, 1968, 2(1), The calmodulin-sensitive adenylate cyclase of Bordatella pertussis: cloning and expression in Escherichia coli.
Hewlett et al., PNAS USA 73, 6, 1926-1930, 1976.
Novotny et al., Proceedings of the Third International Symposium on Pertussis, 99-123, 1979.
Endoh et al., Microbiol. Immunol. 24, 2, 95-104, 1980.
Chemical Abstracts 96, 1982, 197728e.
Confer et al., Science 217, 948-950, 1982.
Chemical Abstracts 99, 1983, 170610k.
Imaizumi et al., Infection and Immunity 41, 3, 1138-1143, 1983.
Sato et al., J. Microbiol. Methods 1, 99-109, 1983.
Weiss et al., Infection and Immunity 42, 1, 33-41, 1983.
Chemical Abstracts 101, 1984, 18519q.
Moss et al., Annals of Internal Medicine 101, 653-666, 1984.
Weiss et al., J. Infect. Dis. 150, 2, 219-222, Aug. 1984.
Beesley & Novotny, abstract submitted to Annual Histochemistry Meeting, Royal Microscopical Soc., United Kingdom, 8 Jan. 1985.
Montaraz et al., Infection and Immunity 47, 3, 744-751, Mar. 1985.
Novotny et al., Proceedings of the Fourth International Symposium on Pertussis, Geneva, Switzerland, 25-27 Sep. 1984, published in Develop, Biol. Standard 61, 27-41, 1986.
Burroughs Wellcome Co.
Russel Jeffrey E.
LandOfFree
Antigenic preparation and isolation of such preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic preparation and isolation of such preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic preparation and isolation of such preparations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-734352